Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jul 29:7:142.
doi: 10.1186/1475-2875-7-142.

Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children

Daniel Dodoo  1 , Anastasia Aikins, Kwadwo Asamoah Kusi, Helena Lamptey, Ed Remarque, Paul Milligan, Samuel Bosomprah, Roma Chilengi, Yaa Difie Osei, Bartholomew Dicky Akanmori, Michael Theisen
Affiliations

Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children

Daniel Dodoo et al. Malar J. .

Abstract

Background: Antigen-specific antibody-mediated immune responses play an important role in natural protection against clinical malaria, but conflicting estimates of this association have emerged from immuno-epidemiological studies in different geographical settings. This study was aimed at assessing in a standardized manner the relationship between the antibody responses to four malaria vaccine candidate antigens and protection from clinical malaria, in a cohort of Ghanaian children.

Methods: Standardized ELISA protocols were used to measure isotype and IgG subclass levels to Apical Membrane Antigen 1 (AMA1), Merozoite Surface Protein 1-19 (MSP119), Merozoite Surface Protein 3 (MSP3) and Glutamate Rich Protein (GLURP) antigens in plasma samples from 352 Ghanaian children, aged three to 10 years with subsequent malaria surveillance for nine months. This is one of a series of studies in different epidemiological settings using the same standardized ELISA protocols to permit comparisons of results from different laboratories.

Results: The incidence rate of malaria was 0.35 episodes per child per year. Isotype and IgG subclasses for all antigens investigated increased with age, while the risk of malaria decreased with age. After adjusting for age, higher levels of IgG to GLURP, MSP119, MSP3 and IgM to MSP119, MSP3 and AMA1 were associated with decreased malaria incidence. Of the IgG subclasses, only IgG1 to MSP119 was associated with reduced incidence of clinical malaria. A previous study in the same location failed to find an association of antibodies to MSP119 with clinical malaria. The disagreement may be due to differences in reagents, ELISA and analytical procedures used in the two studies. When IgG, IgM and IgG subclass levels for all four antigens were included in a combined model, only IgG1 [(0.80 (0.67-0.97), p = 0.018)] and IgM [(0.48 (0.32-0.72), p < 0.001)] to MSP119 were independently associated with protection from malaria.

Conclusion: Using standardized procedures, the study has confirmed the importance of antibodies to MSP119 in reducing the risk of clinical malaria in Ghanaian children, thus substantiating its potential as a malaria vaccine candidate.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The monthly point prevalence of asymptomatic malaria parasitaemia and incident rate of clinical malaria. The point prevalence of asymptomatic parasitaemia for each month is represented as a bar graph and the pattern of clinical malaria (incident rate) is shown as a line graph.
Figure 2
Figure 2
Baseline IgG and IgM levels in relation to age. The top and bottom panels represents total IgG or IgM levels to AMA1, GLURP, MSP119 and MSP3 in relation to age of Ghanaian children, respectively. The line shows the LOESS smoothed estimate of the geometric mean.
Figure 3
Figure 3
Baseline IgG subclass levels in relation to age. The top, 2nd, 3rd and 4th panels represent IgG subclasses 1 to 4 against AMA1, GLURP, MSP119 and MSP3 in relation to age of Ghanaian children, respectively. The line shows the LOESS smoothed estimate of the geometric mean.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Cohen S, McGREGOR IA, CARRINGTON S. Gamma-globulin and acquired immunity to human malaria. Nature. 1961;192:733–737. doi: 10.1038/192733a0. - DOI - PubMed
    1. Cohen S, Butcher GA. Serum antibody in acquired malarial immunity. Trans R Soc Trop Med Hyg. 1971;65:125–135. doi: 10.1016/0035-9203(71)90210-0. - DOI - PubMed
    1. Good MF. Towards the development of the ideal malaria vaccine. A decade of progress in a difficult field. Med J Aust. 1991;154:284–289. - PubMed
    1. Sabchareon A, Burnouf T, Ouattara D, Attanath P, Bouharoun-Tayoun H, Chantavanich P, Foucault C, Chongsuphajaisiddhi T, Druilhe P. Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. Am J Trop Med Hyg. 1991;45:297–308. - PubMed
    1. Braga EM, Barros RM, Reis TA, Fontes CJ, Morais CG, Martins MS, Krettli AU. Association of the IgG response to Plasmodium falciparum merozoite protein (C-terminal 19 kD) with clinical immunity to malaria in the Brazilian Amazon region. Am J Trop Med Hyg. 2002;66:461–466. - PubMed

Publication types